Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-07-08 Sale |
2020-07-09 4:18 pm |
Fulcrum Therapeutics Inc. | FULC | Wallace Owen B. Chief Scientific Officer |
2,951 | $20 | $59,020 | 209,030 (Direct) |
View |
| 2020-06-30 Sale |
2020-07-01 4:39 pm |
Fulcrum Therapeutics Inc. | FULC | Wallace Owen B. Chief Scientific Officer |
141 | $20 | $2,820 | 211,981 (Direct) |
View |
| 2020-05-28 Sale |
2020-06-01 4:15 pm |
Fulcrum Therapeutics Inc. | FULC | Wallace Owen B. Chief Scientific Officer |
2,232 | $20 | $44,640 | 212,122 (Direct) |
View |
| 2020-05-27 Sale |
2020-05-29 4:15 pm |
Fulcrum Therapeutics Inc. | FULC | Wallace Owen B. Chief Scientific Officer |
448 | $20 | $8,960 | 214,354 (Direct) |
View |
| 2020-05-26 Sale |
2020-05-28 4:16 pm |
Fulcrum Therapeutics Inc. | FULC | Wallace Owen B. Chief Scientific Officer |
412 | $20 | $8,240 | 214,802 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-01-02 Option Award |
2024-01-04 4:15 pm |
N/A 2034-01-01 |
Monte Rosa Therapeutics Inc. | GLUE | Wallace Owen B. Chief Scientific Officer |
119,000 | $0 | 124,266 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-04 4:31 pm |
N/A 2033-01-02 |
Monte Rosa Therapeutics Inc. | GLUE | Wallace Owen B. Chief Scientific Officer |
135,000 | $0 | 135,000 (Direct) |
View |
| 2022-03-01 Option Award |
2022-03-02 6:32 pm |
N/A 2032-02-29 |
Monte Rosa Therapeutics Inc. | GLUE | Wallace Owen B. Chief Scientific Officer |
117,450 | $0 | 117,450 (Direct) |
View |
| 2021-04-12 Option Award |
2021-06-25 5:00 pm |
N/A 2031-04-12 |
Monte Rosa Therapeutics Inc. | GLUE | Wallace Owen B. Chief Scientific Officer |
500,367 | $0 | 500,367 (Direct) |
View |
Ownership |
2021-06-23 8:35 pm |
N/A 2031-04-12 |
Monte Rosa Therapeutics Inc. | GLUE | Wallace Owen B. Chief Scientific Officer |
0 | $0 | 387,069 (Direct) |
View |
| 2020-09-14 Exercise |
2020-09-14 4:19 pm |
N/A N/A |
Fulcrum Therapeutics Inc. | FULC | Wallace Owen B. Chief Scientific Officer |
6,350 | $7.84 | 209,030 (Direct) |
View |
| 2020-09-14 Exercise |
2020-09-14 4:19 pm |
N/A 2029-01-21 |
Fulcrum Therapeutics Inc. | FULC | Wallace Owen B. Chief Scientific Officer |
6,350 | $0 | 209,030 (Direct) |
View |
| 2020-07-08 Exercise |
2020-07-09 4:18 pm |
N/A N/A |
Fulcrum Therapeutics Inc. | FULC | Wallace Owen B. Chief Scientific Officer |
2,951 | $7.84 | 209,030 (Direct) |
View |
| 2020-07-08 Exercise |
2020-07-09 4:18 pm |
N/A 2029-01-21 |
Fulcrum Therapeutics Inc. | FULC | Wallace Owen B. Chief Scientific Officer |
2,951 | $0 | 209,030 (Direct) |
View |
| 2020-06-30 Exercise |
2020-07-01 4:39 pm |
N/A N/A |
Fulcrum Therapeutics Inc. | FULC | Wallace Owen B. Chief Scientific Officer |
141 | $7.84 | 211,981 (Direct) |
View |
| 2020-06-30 Exercise |
2020-07-01 4:39 pm |
N/A 2029-01-21 |
Fulcrum Therapeutics Inc. | FULC | Wallace Owen B. Chief Scientific Officer |
141 | $0 | 211,981 (Direct) |
View |
| 2020-05-28 Exercise |
2020-06-01 4:15 pm |
N/A N/A |
Fulcrum Therapeutics Inc. | FULC | Wallace Owen B. Chief Scientific Officer |
2,232 | $7.84 | 212,122 (Direct) |
View |
| 2020-05-28 Exercise |
2020-06-01 4:15 pm |
N/A 2029-01-21 |
Fulcrum Therapeutics Inc. | FULC | Wallace Owen B. Chief Scientific Officer |
2,232 | $0 | 212,122 (Direct) |
View |
| 2020-05-27 Exercise |
2020-05-29 4:15 pm |
N/A N/A |
Fulcrum Therapeutics Inc. | FULC | Wallace Owen B. Chief Scientific Officer |
448 | $7.84 | 214,354 (Direct) |
View |
| 2020-05-27 Exercise |
2020-05-29 4:15 pm |
N/A 2029-01-21 |
Fulcrum Therapeutics Inc. | FULC | Wallace Owen B. Chief Scientific Officer |
448 | $0 | 214,354 (Direct) |
View |
| 2020-05-26 Exercise |
2020-05-28 4:16 pm |
N/A N/A |
Fulcrum Therapeutics Inc. | FULC | Wallace Owen B. Chief Scientific Officer |
412 | $7.84 | 214,802 (Direct) |
View |
| 2020-05-26 Exercise |
2020-05-28 4:16 pm |
N/A 2029-01-21 |
Fulcrum Therapeutics Inc. | FULC | Wallace Owen B. Chief Scientific Officer |
412 | $0 | 214,802 (Direct) |
View |